These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10829243)

  • 1. Chlamydia pneumoniae infection is not an independent risk factor for arterial disease.
    Haberbosch W; Jantos C
    Herz; 2000 Mar; 25(2):79-83. PubMed ID: 10829243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of atherosclerosis: infectious versus immune pathogenesis. A new concept.
    Bhakdi S
    Herz; 2000 Mar; 25(2):84-6. PubMed ID: 10829244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chlamydia pneumoniae chronic infection in the development of arteriosclerosis].
    Nalepa P
    Pol Merkur Lekarski; 1998 May; 4(23):289-91. PubMed ID: 9825666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease.
    Altman R; Rouvier J; Scazziota A; Absi RS; Gonzalez C
    Clin Cardiol; 1999 Feb; 22(2):85-90. PubMed ID: 10068844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae in atherosclerosis.
    Saikku P
    J Intern Med; 2000 Mar; 247(3):391-6. PubMed ID: 10762457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydia pneumoniae and atherosclerosis].
    Andreasen JJ
    Ugeskr Laeger; 1997 Sep; 159(37):5503-7. PubMed ID: 9312918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of Chlamydia pneumoniae in the pathogenesis of coronary disease].
    Kähler J; Köster R; Bräser JH; Schäfer P; Terres W; Hamm CW; Meinertz T
    Z Kardiol; 1999 Nov; 88(11):885-95. PubMed ID: 10643056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.
    Maass M; Gieffers J; Solbach W
    Herz; 2000 Mar; 25(2):68-72. PubMed ID: 10829241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae, strain TWAR and atherosclerosis.
    Grayston JT; Kuo CC; Campbell LA; Benditt EP
    Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.
    Laurila A; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2910-3. PubMed ID: 9409275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chlamydia pneumoniae and cerebrovascular disease].
    Linares-Palomino J; Gutiérrez J; López-Espada C; Ros E; Moreno J; Pérez T; Rodríguez M; Maroto MC
    Rev Neurol; 2001 Feb 1-15; 32(3):201-6. PubMed ID: 11310268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values].
    Fernández-Miranda C; Paz M; Aranda JL; Fuertes A; Gómez De La Cámara A
    Med Clin (Barc); 2002 Nov; 119(15):561-4. PubMed ID: 12421506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice.
    Blessing E; Nagano S; Campbell LA; Rosenfeld ME; Kuo CC
    Infect Immun; 2000 Dec; 68(12):7195-7. PubMed ID: 11083855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
    Romano Carratelli C; Nuzzo I; Cozzolino D; Bentivoglio C; Paolillo R; Rizzo A
    Int Immunopharmacol; 2006 May; 6(5):848-53. PubMed ID: 16546716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients.
    Fang JC; Kinlay S; Kundsin R; Ganz P
    Am J Cardiol; 1998 Dec; 82(12):1479-83. PubMed ID: 9874051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.